Temporal trends in the incidence and mortality of gallbladder and biliary diseases in mainland China: past trends and future prediction (Preprint)

Author:

Zhu WenxuanORCID,Liu Shixuan,Zhang Zhuomiao,Wang Xu,Du Baofeng,Bai RuhaiORCID

Abstract

BACKGROUND

China is the country with the most gallbladder and biliary diseases (GBDs) deaths.

OBJECTIVE

The objective of this study was to analyze long-term trends in the incidence and mortality of GBDs in mainland China from 1990 to 2019 and to make projections until 2030.

METHODS

Data on GBDs were extracted from the Global Burden of Disease Study 2019. Population data were extracted from the Global Burden of Disease Study 2019 and World Population Prospects 2019. An age-period-cohort framework was used in this study.

RESULTS

The net drift of GBDs incidence was 0.94% (95% CI: 0.88%, 1.00%) for men and 1.29% (95% CI: 1.22%, 1.35%) for women. The net drift for mortality was -1.57% (95% CI: -1.81%, -1.34%) -5.12% (95% CI: -5.38%, -4.86%) for men and -3.32% (95% CI: -3.55%, -3.10%) -6.90% (95% CI: -7.28%, -6.52%) for women. The risk of GBDs increased in the last 20 years in males but decreased in the last 5 years in females, and the risk of GBDs increased with birth cohort progression in females and in males after 2005. For mortality, both period and cohort effects showed a favorable trend (the mortality risk decreased). It is expected that the past trend in terms of increased incidence in males and decreased mortality for both sexes will continue, but the incidence of GBDs in females is expected to decrease in the future. An increasing proportion of elderly individuals are expected to develop GBDs and die.

CONCLUSIONS

In the past three decades, the incidence of GBDs has increased in both sexes, and the mortality rate has decreased. Except for the decreased incidence in females, the past trends will continue in the next decades. A higher proportion of elderly individuals are projected to suffer GBDs and die, thus GBDs in elderly individuals should receive more attention.

CLINICALTRIAL

Trial registration is not applicable in this study.

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3